| scholarly article | Q13442814 |
| P50 | author | Andreas Zeiher | Q501318 |
| John Ioannidis | Q6251482 | ||
| Joseph C. Wu | Q59749300 | ||
| Enrique Lara-Pezzi | Q38362058 | ||
| P2093 | author name string | Joseph A Hill | |
| Philippe Menasché | |||
| Roger J Hajjar | |||
| Walter J Koch | |||
| Lina Badimón | |||
| Jean-Hugues Trouvin | |||
| Peter de Waele | |||
| Valérie Steenwinckel | |||
| Albert F De Felice | |||
| P2860 | cites work | Why most published research findings are false | Q21092395 |
| Palliative Care in the Treatment of Advanced Heart Failure | Q22306344 | ||
| Why Most Discovered True Associations Are Inflated | Q24273233 | ||
| Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure | Q24648449 | ||
| Expression of a β-adrenergic receptor kinase 1 inhibitor prevents the development of myocardial failure in gene-targeted mice | Q24650383 | ||
| Signaling effectors underlying pathologic growth and remodeling of the heart | Q26825154 | ||
| Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies | Q27000263 | ||
| Echocardiographic assessment of myocardial strain | Q27005121 | ||
| Interventions to enhance adherence to medications in patients with heart failure: a systematic review | Q27027670 | ||
| Heart failure and mouse models | Q27686849 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model | Q28243737 | ||
| Angiotensin-neprilysin inhibition versus enalapril in heart failure | Q28247091 | ||
| Trends in prevalence and outcome of heart failure with preserved ejection fraction | Q28252937 | ||
| Left ventricular assist device and drug therapy for the reversal of heart failure | Q28271792 | ||
| Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells | Q28282675 | ||
| How to improve R&D productivity: the pharmaceutical industry's grand challenge | Q28314992 | ||
| Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments | Q28534767 | ||
| Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research | Q29547313 | ||
| Heart disease and stroke statistics--2014 update: a report from the American Heart Association | Q29547691 | ||
| Dose translation from animal to human studies revisited | Q29618049 | ||
| Patient-specific induced pluripotent stem-cell models for long-QT syndrome | Q29620353 | ||
| G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure | Q30487539 | ||
| Influence of chronic captopril therapy on the infarcted left ventricle of the rat. | Q54447887 | ||
| Early Metoprolol Administration Before Coronary Reperfusion Results in Increased Myocardial Salvage | Q56986728 | ||
| Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardio | Q57217547 | ||
| Inhibition of p38 reduces myocardial infarction injury in the mouse but not pig after ischemia-reperfusion | Q57396518 | ||
| Induction of the calcineurin variant CnAβ1 after myocardial infarction reduces post-infarction ventricular remodelling by promoting infarct vascularization | Q57761226 | ||
| Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion | Q64376598 | ||
| Angiotensin converting enzyme inhibition in patients with congestive heart failure | Q67391111 | ||
| Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction | Q69110803 | ||
| Beneficial hemodynamic effects of milrinone in conscious rabbits with chronic aortic regurgitation | Q69110843 | ||
| Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction | Q69827351 | ||
| Effect of flecainide acetate on prevention of electrical induction of ventricular tachycardia and occurrence of ischemic ventricular fibrillation during the early postmyocardial infarction period: evaluation in a conscious canine model of sudden dea | Q70322557 | ||
| Noise raises blood pressure without impairing auditory sensitivity | Q71492792 | ||
| Translation of highly promising basic science research into clinical applications | Q73352986 | ||
| HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis | Q77700153 | ||
| Tridimensional activation patterns of acquired torsade-de-pointes tachycardias in dogs with chronic AV-block | Q80250947 | ||
| Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure | Q80876154 | ||
| Heart failure | Q83475304 | ||
| Mitral regurgitation | Q83629791 | ||
| Echocardiographic imaging in clinical trials: American Society of Echocardiography Standards for echocardiography core laboratories: endorsed by the American College of Cardiology Foundation | Q84135645 | ||
| Drug-induced torsade de pointes arrhythmias in the chronic AV block dog are perpetuated by focal activity | Q84217819 | ||
| Use of Animal Models of Human Disease for Nonclinical Safety Assessment of Novel Pharmaceuticals | Q84961993 | ||
| Time course of hemodynamic changes in rats with healed severe myocardial infarction | Q93514777 | ||
| Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. | Q30539904 | ||
| Genome editing of isogenic human induced pluripotent stem cells recapitulates long QT phenotype for drug testing | Q30586646 | ||
| Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction | Q33273736 | ||
| Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. | Q33722806 | ||
| Volume overload induces differential spatiotemporal regulation of myocardial soluble guanylyl cyclase in eccentric hypertrophy and heart failure | Q33783174 | ||
| Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome | Q33910479 | ||
| Nitroxyl (HNO): A novel approach for the acute treatment of heart failure | Q33946688 | ||
| A catalogue of reporting guidelines for health research | Q34091472 | ||
| Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming | Q34245487 | ||
| Diagnosing the decline in pharmaceutical R&D efficiency | Q34257771 | ||
| Reperfusion-triggered stress protein response in the myocardium is blocked by post-conditioning. Systems biology pathway analysis highlights the key role of the canonical aryl-hydrocarbon receptor pathway. | Q34360887 | ||
| Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction | Q34415281 | ||
| A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse | Q34423842 | ||
| Human stem cells for modeling heart disease and for drug discovery | Q34433363 | ||
| A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators | Q34483643 | ||
| Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable? | Q34510314 | ||
| Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure | Q34620874 | ||
| Optimized delivery system achieves enhanced endomyocardial stem cell retention | Q34756310 | ||
| Sex is a potent modifier of the cardiovascular system | Q35169334 | ||
| Assessing left ventricular systolic dysfunction after myocardial infarction: are ejection fraction and dP/dt(max) complementary or redundant? | Q35900886 | ||
| Stroke volume-to-wall stress ratio as a load-adjusted and stiffness-adjusted indicator of ventricular systolic performance in chronic loading | Q36320912 | ||
| Hyperpolarized (13)C magnetic resonance reveals early- and late-onset changes to in vivo pyruvate metabolism in the failing heart. | Q36540577 | ||
| A review of human pluripotent stem cell-derived cardiomyocytes for high-throughput drug discovery, cardiotoxicity screening, and publication standards | Q36566235 | ||
| Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions | Q36931178 | ||
| Calcium cycling and signaling in cardiac myocytes. | Q36995547 | ||
| New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop | Q37007953 | ||
| Performance of 3-dimensional echocardiography in measuring left ventricular volumes and ejection fraction: a systematic review and meta-analysis | Q37172510 | ||
| Cardioprotection and myocardial reperfusion: pitfalls to clinical application | Q37298516 | ||
| Systems Approaches to Biology and Disease Enable Translational Systems Medicine | Q37352131 | ||
| Recommendations for the evaluation of left ventricular diastolic function by echocardiography | Q37383745 | ||
| Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy | Q37596176 | ||
| Animal models for atrial fibrillation: clinical insights and scientific opportunities. | Q37624219 | ||
| Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart | Q37629277 | ||
| Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. | Q37700043 | ||
| The role of cardiac PET in translating basic science into the clinical arena | Q37875793 | ||
| Right Ventricular Pacing, Mechanical Dyssynchrony, and Heart Failure | Q37970622 | ||
| Transcriptome, Proteome, and Metabolome in Dyssynchronous Heart Failure and CRT | Q37981970 | ||
| Clinical, laboratory, and pacing predictors of CRT response. | Q37987835 | ||
| Animal models of heart failure: a scientific statement from the American Heart Association | Q38010863 | ||
| In vitro uses of human pluripotent stem cell-derived cardiomyocytes. | Q38013733 | ||
| Imaging techniques for cardiac strain and deformation: comparison of echocardiography, cardiac magnetic resonance and cardiac computed tomography | Q38081158 | ||
| Heart Failure Biomarkers | Q38100647 | ||
| Biomarkers of diastolic dysfunction and myocardial fibrosis: application to heart failure with a preserved ejection fraction. | Q38110226 | ||
| Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies | Q38130382 | ||
| Cardiac stem cell biology: glimpse of the past, present, and future. | Q38175372 | ||
| Reducing waste from incomplete or unusable reports of biomedical research | Q38177450 | ||
| Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. | Q38202358 | ||
| Modeling Timothy Syndrome with iPS Cells | Q39214098 | ||
| Stimulation threshold studies and the effect of antiarrhythmic drugs | Q39242045 | ||
| Calcineurin splicing variant calcineurin Aβ1 improves cardiac function after myocardial infarction without inducing hypertrophy. | Q39743659 | ||
| Patient-specific stem cells and cardiovascular drug discovery | Q39930937 | ||
| Influence of neonatal handling on blood pressure, locomotor activity, and preweanling heart rate in spontaneously hypertensive and Wistar Kyoto rats | Q41579979 | ||
| Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock | Q41916009 | ||
| Cardiotonic Activity of Milrinone, a New and Potent Cardiac Bipyridine, on the Normal and Failing Heart of Experimental Animals | Q42243633 | ||
| SUMO-1 gene transfer improves cardiac function in a large-animal model of heart failure. | Q42255809 | ||
| Facilitation of reentry by lidocaine in canine myocardial infarction. | Q42278658 | ||
| Comparative cardiac effects of milrinone and sodium nitroprusside in conscious rats | Q42279455 | ||
| Effects of flecainide on defibrillation thresholds in the anesthetized dog. | Q42640437 | ||
| The ability of denbufylline to inhibit cyclic nucleotide phosphodiesterase and its affinity for adenosine receptors and the adenosine re-uptake site | Q42847770 | ||
| Simple rabbit model of vulnerable atherosclerotic plaque | Q43286181 | ||
| Patterns of left ventricular dilation during the six months after myocardial infarction | Q43638778 | ||
| Electrophysiological mechanism of enhanced susceptibility of hypertrophied heart to acquired torsade de pointes arrhythmias: tridimensional mapping of activation and recovery patterns | Q43904623 | ||
| Beneficial hemodynamic effects of milrinone and enalapril in conscious rats with healed myocardial infarction | Q44856393 | ||
| Lipid lowering reduces oxidative stress and endothelial cell activation in rabbit atheroma | Q46200093 | ||
| Chronic arthritis aggravates vascular lesions in rabbits with atherosclerosis: a novel model of atherosclerosis associated with chronic inflammation | Q46401891 | ||
| Valsartan therapy in heart failure after myocardial infarction: the role of endothelial dependent vasorelaxation | Q46842490 | ||
| Follistatin-like 3 mediates paracrine fibroblast activation by cardiomyocytes | Q47232599 | ||
| How to increase value and reduce waste when research priorities are set. | Q48099005 | ||
| Mouse strain determines the outcome of wound healing after myocardial infarction | Q48560772 | ||
| The concept of multispecies testing in industrial toxicology | Q48819468 | ||
| Generation of pig iPS cells: a model for cell therapy | Q50534411 | ||
| Reverse remodelling and recovery from heart failure are associated with complex patterns of gene expression. | Q54381911 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3-22 | |
| P577 | publication date | 2015-01-21 | |
| P1433 | published in | Journal of Cardiovascular Translational Research | Q6294906 |
| P1476 | title | Guidelines for translational research in heart failure | |
| P478 | volume | 8 |
| Q46489144 | A Natural Model of Mouse Cardiac Myocyte Senescence |
| Q41997489 | Allogenic adipose-derived stem cell therapy overcomes ischemia-induced microvessel rarefaction in the myocardium: systems biology study. |
| Q38546856 | Cardioprotection in ischaemia-reperfusion injury: novel mechanisms and clinical translation |
| Q86494043 | Cell-based therapies for cardiac repair: a meeting report on scientific observations and European regulatory viewpoints |
| Q42346379 | Challenges of Translational Science |
| Q100464550 | Effects on cardiac function, remodeling and inflammation following myocardial ischemia-reperfusion injury or unreperfused myocardial infarction in hypercholesterolemic APOE*3-Leiden mice |
| Q42030547 | Lung ultrasound as a translational approach for non-invasive assessment of heart failure with reduced or preserved ejection fraction in mice |
| Q47228768 | New pulmonary hypertension model in conscious dogs to investigate pulmonary-selectivity of acute pharmacological interventions |
| Q38859866 | Phase 4 Studies in Heart Failure - What is Done and What is Needed? |
| Q54246308 | Reproducibility Issues: Avoiding Pitfalls in Animal Inflammation Models. |
| Q53185348 | Serum Amyloid P-Component Prevents Cardiac Remodeling in Hypertensive Heart Disease |
| Q30654383 | Small-molecule activation of SERCA2a SUMOylation for the treatment of heart failure |
| Q42005448 | Systolic Dysfunction in Infarcted Mice Does Not Necessarily Lead to Heart Failure: Need to Refine Preclinical Models. |
| Q36314795 | Targeting chronic cardiac remodeling with cardiac progenitor cells in a murine model of ischemia/reperfusion injury |
| Q27335541 | Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology |
Search more.